影像 CRO 市场按服务类型、影像方式、治疗领域、临床试验阶段、最终用户和地区划分

2025 年全球影像 CRO 市场规模估计为 56.1 亿美元，预计到 2032 年将达到 96.8 亿美元，2025 年至 2032 年的复合年增长率为 8.1%。

全球影像 CRO 市场已成为医疗保健产业的关键领域，在医学成像技术的开发和开拓中发挥关键作用。影像 CRO（合约研究组织）专门提供广泛的服务，包括影像通讯协定设计、影像撷取、分析和解释，以支援临床试验和研究。这些组织利用尖端技术和专业知识来提供高品质的影像数据，使製药和生物技术公司能够在药物开发过程中做出明智的决策。慢性病的增加、对个人化医疗的不断增长的需求以及对高效且具有成本效益的药物开发的需求正在推动全球影像 CRO 市场的成长。随着医疗保健格局的不断发展，影像 CRO 在加速创新治疗方法的开发和改善患者预后方面的作用变得越来越重要。

市场动态

全球影像 CRO 市场的成长受到多种关键因素的驱动，例如慢性病的流行、对先进成像技术不断增长的需求，以及对高效且经济的药物开发流程日益增长的需求。人口老化和生活方式的改变使癌症、心血管疾病和神经系统疾病等慢性疾病的盛行率不断上升，这些疾病需要先进的影像技术进行诊断和监测。此外，个人化医疗的出现使得标靶治疗的发展成为必要，而标靶治疗在很大程度上依赖影像生物标记来选择患者和评估治疗反应。然而，影像设备高成本、监管要求复杂以及该领域熟练专业人员短缺等因素可能会抑制市场成长。

此外，影像方案和资料管理缺乏标准化，也为影像合约研究组织 (CRO) 带来挑战，使其难以确保不同机构和研究之间影像资料的可靠性和可重复性。儘管面临这些挑战，但人工智慧、机器学习和云端运算等技术进步正在改变诊断影像领域，市场也提供了巨大的成长机会。这些技术能够更快、更准确地进行影像分析，简化资料管理，并促进相关人员之间的远端协作。此外，PET/CT 和 PET/MRI 等混合影像模式的日益普及，预计将扩大影像合约研究组织 (CRO) 支援多模态影像研究的范围。

本研究的主要特点

• 本报告对全球影像 CRO 市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
• 它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
• 全球成像 CRO 市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
• 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球成像 CRO 市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
• 相关人员可以透过用于分析全球成像 CRO 市场的各种策略矩阵来更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规与趋势分析

• 市场动态
• 驱动程式
• 限制因素
• 机会
• 影响分析
• 主要进展
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景
• 产业趋势

4. 2020 年至 2032 年全球影像 CRO 市场（依服务类型）

• 临床试验影像
• 临床前影像
• 医学影像资料管理
• 影像处理与分析服务
• 监理咨询
• 其他（品管等）

5. 2020 年至 2032 年全球影像 CRO 市场（以影像方式划分）

• 磁振造影（MRI）
• 电脑断层扫描（CT）
• 正子断层扫描（PET）
• 超音波
• X射线
• 光学成像

6. 2020 年至 2032 年按治疗领域分類的全球影像 CRO 市场

• 肿瘤学
• 神经病学
• 心臟病学
• 肌肉骨骼疾病
• 胃肠病学
• 内分泌学
• 其他的

7. 2020 年至 2032 年按临床试验阶段分類的全球影像 CRO 市场

• 第一阶段
• 第二阶段
• 第三阶段
• 第四阶段

8. 2020 年至 2032 年全球影像 CRO 市场（依最终使用者划分）

• 製药公司
• 生技公司
• 医疗设备製造商
• 诊断中心
• 受託研究机构
• 学术研究所

9. 全球影像 CRO 市场（按地区划分），2020 年至 2032 年

• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中部非洲

第十章 竞争格局

• Siemens Healthineers
• GE Healthcare
• Philips Healthcare
• Canon Medical Systems
• Fujifilm Holdings Corporation
• Agfa-Gevaert Group
• Hitachi Medical Corporation
• Carestream Health
• Hologic, Inc.
• Toshiba Medical Systems
• Mindray Medical International Limited
• Varian Medical Systems
• Esaote SpA
• Bracco Imaging SpA
• Leica Biosystems

第 11 章分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十二章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Global Imaging CRO Market is estimated to be valued at USD 5.61 Bn in 2025 and is expected to reach USD 9.68 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.

The global imaging CRO market has emerged as a crucial sector within the healthcare industry, playing a pivotal role in the development and advancement of medical imaging technologies. Imaging Contract Research Organizations (CROs) specialize in providing a wide range of services, including imaging protocol design, image acquisition, analysis, and interpretation, to support clinical trials and research studies. These organizations leverage cutting-edge technologies and expertise to deliver high-quality imaging data, enabling pharmaceutical and biotechnology companies to make informed decisions during the drug development process. The increasing prevalence of chronic diseases, coupled with the growing demand for personalized medicine and the need for efficient and cost-effective drug development, has fueled the growth of the global imaging CRO market. As the healthcare landscape continues to evolve, the role of imaging CROs is becoming increasingly important in accelerating the development of innovative therapies and improving patient outcomes.

Market Dynamics

The global imaging CRO market growth is driven by several key factors, including the increasing prevalence of chronic diseases, rising demand for advanced imaging technologies, and the growing need for efficient and cost-effective drug development processes. The aging population and changing lifestyles have led to a higher incidence of chronic conditions such as cancer, cardiovascular diseases, and neurological disorders, which require advanced imaging techniques for diagnosis and monitoring. Additionally, the advent of personalized medicine has necessitated the development of targeted therapies, which rely heavily on imaging biomarkers for patient selection and treatment response assessment. However, the market growth may be restrained by factors such as the high cost of imaging equipment, complex regulatory requirements, and the shortage of skilled professionals in the field.

Furthermore, the lack of standardization in imaging protocols and data management poses challenges for imaging CROs in ensuring the reliability and reproducibility of imaging data across different sites and studies. Despite these challenges, the market presents significant opportunities for growth, driven by technological advancements such as artificial intelligence, machine learning, and cloud computing, which are transforming the imaging landscape. These technologies enable faster and more accurate image analysis, streamline data management, and facilitate remote collaboration among stakeholders. Moreover, the increasing adoption of hybrid imaging modalities, such as PET/CT and PET/MRI, is expected to expand the scope of Imaging CROs in supporting multimodal imaging studies.

Key Features of the Study

• This report provides in-depth analysis of the global imaging CRO market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Imaging CRO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Fujifilm Holdings Corporation, Agfa-Gevaert Group, Hitachi Medical Corporation, Carestream Health, Hologic, Inc., Toshiba Medical Systems, Mindray Medical International Limited, Varian Medical Systems, Esaote S.p.A., Bracco Imaging S.p.A., and Leica Biosystems
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global imaging CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global imaging CRO market

Market Segmentation

• Service Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Clinical Trial Imaging
  • Preclinical Imaging
  • Medical Imaging Data Management
  • Image Processing & Analysis Services
  • Regulatory Consultancy
  • Others (Quality Control, etc.)
• Imaging Modality Insights (Revenue, USD Bn, 2020 - 2032)
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Positron Emission Tomography (PET)
  • Ultrasound
  • X-ray
  • Optical Imaging
• Therapeutic Area Insights (Revenue, USD Bn, 2020 - 2032)
  • Oncology
  • Neurology
  • Cardiology
  • Musculoskeletal Disorders
  • Gastroenterology
  • Endocrinology
  • Others
• Clinical Trial Phase Insights (Revenue, USD Bn, 2020 - 2032)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Manufacturers
  • Diagnostic Centers
  • Contract Research Organizations
  • Academic and Research Institutes
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Siemens Healthineers
  • GE Healthcare
  • Philips Healthcare
  • Canon Medical Systems
  • Fujifilm Holdings Corporation
  • Agfa-Gevaert Group
  • Hitachi Medical Corporation
  • Carestream Health
  • Hologic, Inc.
  • Toshiba Medical Systems
  • Mindray Medical International Limited
  • Varian Medical Systems
  • Esaote S.p.A.
  • Bracco Imaging S.p.A.
  • Leica Biosystems

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Imaging CRO Market, By Service Type
  • Global Imaging CRO Market, By Imaging Modality
  • Global Imaging CRO Market, By Therapeutic Area
  • Global Imaging CRO Market, By Clinical Trial Phase
  • Global Imaging CRO Market, By End User
  • Global Imaging CRO Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Imaging CRO Market, By Service Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Clinical Trial Imaging
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Preclinical Imaging
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Medical Imaging Data Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Image Processing & Analysis Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Regulatory Consultancy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Quality Control, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Imaging CRO Market, By Imaging Modality, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Magnetic Resonance Imaging (MRI)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Computed Tomography (CT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Positron Emission Tomography (PET)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ultrasound
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• X-ray
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Optical Imaging
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Imaging CRO Market, By Therapeutic Area, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Musculoskeletal Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gastroenterology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Endocrinology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Imaging CRO Market, By Clinical Trial Phase, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Phase I
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Phase II
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Phase III
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Phase IV
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Imaging CRO Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Medical Device Manufacturers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Contract Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Imaging CRO Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Philips Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Canon Medical Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fujifilm Holdings Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agfa-Gevaert Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hitachi Medical Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Carestream Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hologic, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Toshiba Medical Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mindray Medical International Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Varian Medical Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Esaote S.p.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bracco Imaging S.p.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Leica Biosystems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us